α-Enolase–binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

α-Enolase–binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer

Published:2015-06-03 Issue:290 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Wu Chien-Hsun¹²,Kuo Yi-Huei²,Hong Ruey-Long³,Wu Han-Chung¹²

Affiliation:

1. Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 114, Taiwan.

2. Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 115, Taiwan.

3. Department of Oncology, National Taiwan University Hospital, Taipei 100, Taiwan.

Abstract

α-Enolase–targeted lipid nanoparticles containing chemotherapeutic drugs are effective for the treatment of colorectal cancer.

Funder

National Science Council

Academia Sinica, Ministry of Science and Technology

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference43 articles.

1. Nanocarriers as an emerging platform for cancer therapy

2. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

3. Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy

4. Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications

5. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma;Lopes de Menezes D. E.;Cancer Res.,1998

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current landscape of mRNA technologies and delivery systems for new modality therapeutics;Journal of Biomedical Science;2024-09-10

2. An overview on recent approaches for colonic drug delivery systems;Pharmaceutical Development and Technology;2024-06-20

3. Doxorubicin-based ENO1 targeted drug delivery strategy enhances therapeutic efficacy against colorectal cancer;Biochemical Pharmacology;2024-06

4. Drug delivery systems for colorectal cancer chemotherapy;Chinese Chemical Letters;2024-02

5. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review;Biomedicine & Pharmacotherapy;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3